185 related articles for article (PubMed ID: 36171344)
1. Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide.
Schulz J; Michelet R; Zeitlinger M; Mikus G; Kloft C
Pharm Res; 2022 Nov; 39(11):2991-3003. PubMed ID: 36171344
[TBL] [Abstract][Full Text] [Related]
2. Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in Humans.
Schulz J; Michelet R; Zeitlinger M; Mikus G; Kloft C
Pharm Res; 2022 Dec; 39(12):3279-3291. PubMed ID: 36271205
[TBL] [Abstract][Full Text] [Related]
3. A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications.
Schulz J; Michelet R; Joseph JF; Zeitlinger M; Schumacher F; Mikus G; Kloft C
J Pharm Biomed Anal; 2022 Feb; 210():114551. PubMed ID: 34999435
[TBL] [Abstract][Full Text] [Related]
4. Contribution of voriconazole N-oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection.
Boglione-Kerrien C; Morcet J; Scailteux LM; Bénézit F; Camus C; Mear JB; Gangneux JP; Bellissant E; Tron C; Verdier MC; Lemaitre F
Mycoses; 2023 May; 66(5):396-404. PubMed ID: 36698317
[TBL] [Abstract][Full Text] [Related]
5. Quantification of microdialysis related variability in humans: Clinical trial design recommendations.
Busse D; Simon P; Michelet R; Ehmann L; Mehner F; Dorn C; Kratzer A; Huisinga W; Wrigge H; Petroff D; Kloft C
Eur J Pharm Sci; 2021 Feb; 157():105607. PubMed ID: 33141034
[TBL] [Abstract][Full Text] [Related]
6. High voriconazole target-site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long-term microdialysis.
Kirbs C; Kluwe F; Drescher F; Lackner E; Matzneller P; Weiss J; Zeitlinger M; Kloft C
Eur J Pharm Sci; 2019 Apr; 131():218-229. PubMed ID: 30731238
[TBL] [Abstract][Full Text] [Related]
7. Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug.
Araujo BV; Silva CF; Haas SE; Dalla Costa T
J Pharm Biomed Anal; 2008 Aug; 47(4-5):876-81. PubMed ID: 18395391
[TBL] [Abstract][Full Text] [Related]
8. Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients.
Li ZW; Peng FH; Yan M; Liang W; Liu XL; Wu YQ; Lin XB; Tan SL; Wang F; Xu P; Fang PF; Liu YP; Xiang DX; Zhang BK
Ther Drug Monit; 2017 Aug; 39(4):422-428. PubMed ID: 28604474
[TBL] [Abstract][Full Text] [Related]
9. Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings.
Simmel F; Kloft C
Int J Clin Pharmacol Ther; 2010 Nov; 48(11):695-704. PubMed ID: 20979927
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction.
Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ
Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring.
Eiden C; Cociglio M; Hillaire-Buys D; Eymard-Duvernay S; Ceballos P; Fegueux N; Peyrière H
Xenobiotica; 2010 Oct; 40(10):701-6. PubMed ID: 20642349
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Marshall WL; McCrea JB; Macha S; Menzel K; Liu F; van Schanke A; de Haes JIU; Hussaini A; Jordan HR; Drexel M; Kantesaria BS; Tsai C; Cho CR; Hulskotte EGJ; Butterton JR; Iwamoto M
J Clin Pharmacol; 2018 Jul; 58(7):897-904. PubMed ID: 29578577
[TBL] [Abstract][Full Text] [Related]
13. Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels.
Gautier-Veyret E; Fonrose X; Tonini J; Thiebaut-Bertrand A; Bartoli M; Quesada JL; Bulabois CE; Cahn JY; Stanke-Labesque F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2305-14. PubMed ID: 25645831
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of FMO3 Variants on Plasma Disposition and Adverse Reactions of Oral Voriconazole in Febrile Neutropenia.
Wang X; Zhao J; Wen T; Liao X; Luo B
Pharmacology; 2021; 106(3-4):202-210. PubMed ID: 32998136
[TBL] [Abstract][Full Text] [Related]
15. Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism.
Schulz J; Thomas A; Saleh A; Mikus G; Kloft C; Michelet R
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335853
[TBL] [Abstract][Full Text] [Related]
16. Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans.
Simmel F; Kirbs C; Erdogan Z; Lackner E; Zeitlinger M; Kloft C
AAPS J; 2013 Jan; 15(1):95-103. PubMed ID: 23065438
[TBL] [Abstract][Full Text] [Related]
17. Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis.
Alves IA; Staudt KJ; Silva CM; Lock GA; Dalla Costa T; de Araujo BV
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483963
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.
Chen W; Xie H; Liang F; Meng D; Rui J; Yin X; Zhang T; Xiao X; Cai S; Liu X; Li Y
Biol Pharm Bull; 2015; 38(7):996-1004. PubMed ID: 26133710
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.
Lin XB; Huang F; Tong L; Xia YZ; Wu JJ; Li J; Hu XG; Liang T; Liu XM; Zhong GP; Cai CJ; Chen X
Int J Infect Dis; 2020 Apr; 93():345-352. PubMed ID: 32109625
[TBL] [Abstract][Full Text] [Related]
20. Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.
Yasu T; Konuma T; Kato S; Kurokawa Y; Takahashi S; Tojo A
Ann Hematol; 2016 Oct; 95(11):1845-51. PubMed ID: 27535751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
